Abiomed Inc – Company Profile and SWOT Analysis

Abiomed Inc – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Scope

• Detailed information on Abiomed Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Abiomed Inc in the form of a SWOT analysis

• An in-depth view of the business model of Abiomed Inc including a breakdown and examination of key business segments

• News about Abiomed Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Abiomed Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Abiomed Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Abiomed Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Terumo Corp

Getinge AB

Medtronic Plc

Edwards Lifesciences Corp

LivaNova Plc

Boston Scientific Corp

Abbott Laboratories

Teleflex Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Abiomed Inc - Key Facts

Abiomed Inc - Key Employees

Abiomed Inc - Key Employee Biographies

Abiomed Inc - Major Products and Services

Abiomed Inc - History

Abiomed Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Abiomed Inc - Business Description

R&D Overview

Abiomed Inc - Corporate Strategy

Abiomed Inc - SWOT Analysis

SWOT Analysis - Overview

Abiomed Inc - Strengths

Abiomed Inc - Weaknesses

Abiomed Inc - Opportunities

Abiomed Inc - Threats

Abiomed Inc - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Abiomed Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Abiomed Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Abiomed Inc, Recent Deals Summary

Section 4 – Company’s Recent Developments

Nov 02, 2022: Johnson & Johnson agrees to buy Abiomed for $16.6bn

Nov 01, 2022: Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency, up 7% on a Reported Basis Year Over Year

Oct 13, 2022: Abiomed announces Second Quarter Fiscal 2023 Earnings and Conference Call Notification

Sep 13, 2022: TCT 2022: Impella enables complete revascularization, improved quality of life and native heart recovery

Aug 04, 2022: ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency

Jul 14, 2022: Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification

May 31, 2022: Abiomed to Present at the William Blair 42nd Annual Growth Stock Conference

Apr 28, 2022: Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year

Apr 08, 2022: Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification

Mar 21, 2022: Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French

Section 5 – Appendix

Methodology

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Abiomed Inc, Key Facts

Abiomed Inc, Key Employees

Abiomed Inc, Key Employee Biographies

Abiomed Inc, Major Products and Services

Abiomed Inc, History

Abiomed Inc, Subsidiaries

Abiomed Inc, Key Competitors

Abiomed Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Abiomed Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Abiomed Inc, Recent Deals Summary

List of Figures

List of Figures

Abiomed Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Abiomed Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports